CDTX vs EXC · rev $1.3M vs P/E 17, rev $23.03B
Cidara Therapeutics Inc (CDTX) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
CDTX currently screens at market cap $6.96B. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the CDTX and EXC stock pages for the full models.
Not investment advice.